GLP-2 TZ Peptide Analog — For Research Use Only
Research Use Only. All products currently listed on this site are for research purposes only. Products are not intended for human or animal consumption, dosing, injection, ingestion, or therapeutic use.
Inventory waitlist open — documentation available now
FOR RESEARCH USE ONLY. Not for human consumption, medical use, or therapeutic application of any kind.
Batch specifications
- Compound
- GLP-2 Peptide Analog (Tirzepatide)
- Net quantity
- 30 mg
- Form
- Lyophilized powder
- HPLC purity
- ≥99%
- Current lot
DP-GLP2-001- Testing panel
- HPLC · Mass Spec · LAL Endotoxin
- Storage
- 2–8°C, protected from light
Certificate of Analysis
Each vial includes a QR code linked to that batch's COA on Freedom Diagnostics. No paper certificate is included — scan the code to verify HPLC purity, mass spectrometry identity, and LAL endotoxin results.
Join the inventory waitlist. This batch is not yet available to order. Review the COA and specifications above, then request notification when inventory opens.
Request inventory alert
Description
FOR RESEARCH USE ONLY. Not for human consumption, medical use, or therapeutic application of any kind.
A synthetic peptide analog studied in vitro as a dual agonist of the GIP and GLP-1 receptors. In cell-based assays using lines recombinantly expressing the GIP receptor or GLP-1 receptor, it has been characterized for stimulation of cAMP accumulation at each receptor, with published work examining its relative potency and receptor-binding affinity across these in vitro systems.
Research Specifications
- Purity: 99%+ (HPLC — Freedom Diagnostics)
- Testing: HPLC · Mass Spectrometry · LAL Endotoxin
- Form: Lyophilized powder
- Storage: 2–8°C, protected from light
Why Researchers Choose This Catalog
- Third-party verified purity — every batch, not sampled
- Mass spectrometry confirmation of identity
- Endotoxin-screened (LAL method)
- QR code on every vial links to Freedom Diagnostics COA lookup
- Lot-numbered inventory with corresponding batch documentation
